Cardiogenic shock is a clinical syndrome associated with a high risk for mortality, with little improvement in outcomes over recent decades. The authors noted that the lack of a uniform definition has ...
Cardiogenic shock care extends beyond rapid decision-making at the bedside, a new review asserts. Clearer understanding of shock’s diversity and how best to tackle its acute manifestations, as well as ...
More than a quarter of patients with early-stage cardiogenic shock had to be transferred to a higher level of care, progressed to a worse stage of shock, or died, according to a study in six US ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
In cardiogenic shock, the heart is unable to pump sufficient blood to supply vital organs. Cardiogenic shock is the leading cause of death in patients with acute myocardial infarction (MI). The ...
The Company recently announced the positive topline results from the Phase 2b study with istaroxime in acute heart failure patients with early cardiogenic shock WARRINGTON, Pa., Oct. 09, 2024 (GLOBE ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results